Horton v. Teva Pharmaceuticals USA, Inc., et al.
| Jennifer Horton |
| Teva Women's Health Inc doing business as Teva Women's Health LLC, Teva Pharmaceuticals USA Inc, Teva Women's Health LLC, Coopersurgical Inc and Cooper Companies, Inc. |
| 1:2021cv02435 |
| June 15, 2021 |
| US District Court for the Northern District of Georgia |
| Leigh Martin May |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. § 1332 |
| Both |
Docket Report
RSS Track this Docket
This docket was last retrieved on August 12, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 19 AMENDED COMPLAINT SHORT FORM COMPLAINT against Cooper Companies, Inc., Coopersurgical Inc, Teva Pharmaceuticals USA Inc, Teva Women's Health LLC, Teva Branded Pharmaceutical Products R&D, Inc. with Jury Demand filed by Jennifer Horton.(Driscoll, John) Please visit our website at http://www.gand.uscourts.gov/commonly-used-forms to obtain Pretrial Instructions and Pretrial Associated Forms which includes the Consent To Proceed Before U.S. Magistrate form. |
Filing 18
Case Management Order Regarding Docket Logistics of Filing of Short Form Complaints, Executed Waivers of Service of Summons of Process, and Notices of Appearance in Individual Cases. Signed by Judge Leigh Martin May on 7/21/2021. Associated Cases: 1:20-md-02974-LMM et al.(rjc)
|
|
Filing 17
ORDER INITIAL CONFERENCE: The Court held its Initial Conference in this MDL on February 9, 2021. The below are the orders entered after discussion of these issues at that conference. 1. Leadership structure: After the Court discussed issues concerning the leadership structure with all parties, the Court ORDERED Plaintiffs and Defendants to each file their proposed consent motion and order as to their requested leadership structure and team within 7 days of the date of this order. 2. Future status conferences: The Court will hold status conferences once a month. The next six conferences will take place on the following dates at 10:00 am via zoom: Tuesday, March 9, 2021; Monday, April 12, 2021; Wednesday, May 12, 2021; Monday, June 14, 2021; Tuesday, July 13, 2021; Friday, August 20, 2021. The Court will send out the zoom links prior to the conferences. The parties will submit a proposed consent agenda 3 business days prior to the conference. The parties will also confer as to the format for presenting issues that require additional explanation. When these are necessary, they should also be filed 3 business days before the conference. 3. Stay of responsive pleading obligations: The Court continues the stay of responsive pleading obligations provided for in Section 6(b) of the Court's initial order. 4. Pending motions: The Court DENIES WITHOUT PREJUDICE all pending motions in the individual cases comprising the MDL. These cases are also ADMINISTRATIVELY CLOSED. These terminated motions will later be refiled in accordance with an upcoming Case Management Order. 5. Docketing: All parties are to docket future filings only in the MDL case. The case caption should indicate whether any filing applies to all cases or list the individual cases to which it should apply. 6. Electronic service: The Court ORDERS all attorneys participating in the MDL proceeding to register with the Court's CM/ECF system. Because all attorneys will then receive electronic copies of documents filed in the MDL, the Court ORDERS that electronic service of documents via the Court's CM/ECF system satisfies the obligation of service. Hereafter, unless otherwise ordered, neither the clerk's office nor counsel for the parties shall be obligated to provide service copies of any filings or related orders by U.S. Mail or any other means to attorneys who have not registered with the Court's CM/ECF system. An attorney who is not participating in the MDL and does not want to receive CM/ECF notifications may file a motion to withdraw or a certificate of consent to withdraw in accordance with Local Rule 83.1(E). 7. Initial disclosures: The Court GRANTS the parties' joint request for the Court to excuse the parties from Rule 26(f) initial disclosures; except as to the ParaGard New Drug Application (NDA) that was transferred on or about November 10, 2005, to Duramed Pharmaceuticals, Inc., and produced by TWH, Inc., to plaintiff in the Estrada case. 8. Case management and initial orders: The parties are ORDERED to confer as to proposed orders for the list found herein. See order for further specifics and instructions. Signed by Judge Leigh Martin May on 2/10/2021.(tmf)
|
| Filing 16 Case transferred in from District of Illinois Southern; Case Number 3:21-cv-00523. Original file certified copy of transfer order and docket sheet received. |
| Clerk's Certificate of Mailing as to John J. Driscoll, Booker T. Coleman, Jr. re #17 Order. (tmf) |
| Civil Case Terminated. (tmf) |
| Filing 15 CONDITIONAL TRANSFER ORDER (CTO-24) TRANSFERRING CASE TO OTHER DISTRICT: Case transferred to Northern District of Georgia and MDL No 2974 In Re: Paragard IUD Products Liability Litigation. (Attachments: #1 Minute Order)(kek) [Transferred from Illinois Southern on 6/15/2021.] |
|
Filing 14
ORDER GRANTING the defendants' #13 Agreed Motion to Extend Defendants' Responsive Pleading Deadline. They now have until June 18, 2021, to answer or otherwise plead. Signed by Judge J. Phil Gilbert on 6/4/2021. (cab). THIS TEXT ENTRY IS AN ORDER OF THE COURT. NO FURTHER DOCUMENTATION WILL BE MAILED. [Transferred from Illinois Southern on 6/15/2021.]
|
| Action due by 6/18/2021, per Order at Doc. 14. (kls3) [Transferred from Illinois Southern on 6/15/2021.] |
| Filing 13 MOTION for Extension of Time to File Answer AGREED MOTION TO EXTEND DEFENDANTS' RESPONSIVE PLEADINGS DEADLINE by Cooper Companies, Inc., CooperSurgical, Inc., Teva Pharmaceuticals USA, Inc., Teva Women's Health, Inc.. (Coleman, Booker) [Transferred from Illinois Southern on 6/15/2021.] |
| Filing 12 CJRA TRACK B assigned: The Final Pretrial Conference is scheduled for 6/8/2022 at 9:00 AM with a Jury Trial date of 6/20/2022 at 9:00 AM in Benton Courthouse before Judge J. Phil Gilbert. Parties are to submit a Joint Report regarding Proposed Scheduling and Discovery Order within 21 days of the entry of this filing. Scheduling/Discovery and Settlement Conferences will NOT be set for hearing unless requested by the parties or deemed necessary by the Court. (tag) [Transferred from Illinois Southern on 6/15/2021.] |
| Filing 11 NOTICE REGARDING FILING re #3 Notice of Appearance filed by Teva Pharmceuticals USA, Inc., CooperSurgical, Inc., Cooper Companies, Inc., Teva Women's Health, LLC, Teva Women's Health, Inc. The document submitted is a fillable document. Fillable documents should be converted to non-fillable PDF documents before filing on CM/ECF. This Notice is sent for informational purposes only. (kls3)THIS TEXT ENTRY IS AN ORDER OF THE COURT. NO FURTHER DOCUMENTATION WILL BE MAILED. [Transferred from Illinois Southern on 6/15/2021.] |
| Filing 10 Notice of Judge Assignment. Judge J. Phil Gilbert assigned. All future documents must bear case number 3:21-cv-523-JPG. Refer to Civil/Removal Case Processing Requirements, found on the ILSD website, for further service information. (kls3) [Transferred from Illinois Southern on 6/15/2021.] |
| Filing 9 Teva Women's Health LLC's Answer to First Amended Complaint ANSWER to Complaint by Teva Womens Health LLC.(Coleman, Booker) [Transferred from Illinois Southern on 6/15/2021.] |
| Filing 8 Corporate Disclosure Statement by Cooper Surgical Inc. (Coleman, Booker) [Transferred from Illinois Southern on 6/15/2021.] |
| Filing 7 Corporate Disclosure Statement by Cooper Companies Inc. (Coleman, Booker) [Transferred from Illinois Southern on 6/15/2021.] |
| Filing 6 Corporate Disclosure Statement by Teva Womens Health Inc. (Coleman, Booker) [Transferred from Illinois Southern on 6/15/2021.] |
| Filing 5 Corporate Disclosure Statement by Teva Womens Health LLC. (Coleman, Booker) [Transferred from Illinois Southern on 6/15/2021.] |
| Filing 4 Corporate Disclosure Statement by Teva Pharmceuticals USA, Inc.. (Coleman, Booker) [Transferred from Illinois Southern on 6/15/2021.] |
| Filing 3 NOTICE of Appearance by Booker T. Coleman, Jr on behalf of Cooper Companies Inc, Cooper Surgical Inc, Teva Pharmceuticals USA, Inc., Teva Womens Health Inc, Teva Womens Health LLC (Coleman, Booker) [Transferred from Illinois Southern on 6/15/2021.] |
| Filing 2 EXHIBIT by Cooper Companies Inc, Cooper Surgical Inc, Teva Pharmceuticals USA, Inc., Teva Womens Health Inc, Teva Womens Health LLC. Exhibit to #1 Notice of Removal, Civil Coversheet with Attachment. (Attachments: #1 Civil Cover Sheet Attachment)(Coleman, Booker) [Transferred from Illinois Southern on 6/15/2021.] |
| Filing 1 NOTICE OF REMOVAL from Circuit Court of Illinois 20th Judicial Circuit, St. Clair County, case number 21L0340 ( Filing fee $ 402 receipt number 0754-4491233), filed by Cooper Companies Inc, Teva Pharmceuticals USA, Inc., Teva Womens Health Inc, Cooper Surgical Inc, Teva Womens Health LLC. (Attachments: #1 Exhibit A, #2 Exhibit B)(Coleman, Booker) [Transferred from Illinois Southern on 6/15/2021.] |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Georgia Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
